QT interval prolongation and rhabdomyolysis associated with diphenhydramine toxicity: a case report

J Community Hosp Intern Med Perspect. 2020 May 21;10(2):151-153. doi: 10.1080/20009666.2020.1749511.

Abstract

Diphenhydramine is a widely available, over-the-counter medication used for allergies and as a sleeping aid. When used in prescription doses, it is generally safe. Overdose of the medication has been associated with dangerous and life-threatening outcomes. Our case describes diphenhydramine toxicity manifesting with two rare but potentially life-threatening complications, rhabdomyolysis, and QT prolongation. Laboratory testing for diphenhydramine levels are not widely available. We recommend a high degree of suspicion for these complications when evaluating patients with diphenhydramine overdose, to adequately manage and prevent untoward outcomes.

Keywords: Diphenhydramine toxicity; QTC prolongation; anticholinergic toxidrome; rhabdomyolysis.

Publication types

  • Case Reports